Tadalafil Tablet, Film Coated
Product Images NDC 68788-8153

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 68788-8153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tadalafil Figure1)

A set of four line graphs displaying the differences in systolic and diastolic blood pressure (BP) between Tadalafil and placebo over time in hours. The graphs are titled Standing Systolic BP, Standing Diastolic BP, Supine Systolic BP, and Supine Diastolic BP, showing BP changes from 0 to 96 hours with error bars indicating variability.*

FDA Label Image

Figure (Tadalafil Figure2)

A two-part line graph showing systolic blood pressure (BP) changes over 24 hours post-dose, comparing Tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg. The upper graph represents standing systolic BP, and the lower graph shows supine systolic BP, both plotted in mmHg over time (hours).*

FDA Label Image

Figure (Tadalafil Figure3)

A line graph showing changes in systolic blood pressure (mmHg) over 12 hours following administration of 20 mg tadalafil or placebo, each combined with 8 mg doxazosin at 08:00. The graph compares results for 08:00 and 20:00 dosing times using different plotted lines for each condition.*

FDA Label Image

Figure (Tadalafil Figure4)

A line chart depicting plasma tadalafil concentration (µg/L) over time (hours). It compares single 20-mg and 5-mg tadalafil doses and once-daily 5-mg tadalafil after 5 consecutive days. Data points with error bars illustrate concentration changes up to 120 hours post-dose.*

FDA Label Image

Figure 5 (Tadalafil Figure5)

A line graph depicting the change from baseline in IPSS total score over a 12-week treatment period. It compares tadalafil 5 mg (solid line with circles) and placebo (dashed line with triangles), showing greater score reduction with tadalafil over time. A significance marker (p<0.01) is noted at week 12.*

FDA Label Image

Figure 6 (Tadalafil Figure6)

A line graph comparing the change from baseline in IPSS total score over 12 weeks of treatment between tadalafil 5 mg and placebo. The x-axis shows duration of treatment in weeks, and the y-axis shows change in IPSS score. The tadalafil group shows a greater decrease in score over time compared to placebo, with statistical significance noted.*

FDA Label Image

Figure 7 (Tadalafil Figure7)

Line graph showing the change from baseline over weeks of therapy comparing Tadalafil/Finasteride and Placebo/Finasteride. The vertical axis measures least-squares mean change from baseline, and the horizontal axis represents time points at 0, 4, 12, and 26 weeks. The graph highlights mean treatment differences with statistical significance annotations at weeks 4, 12, and 26.*

FDA Label Image

Figure 8 (Tadalafil Figure8)

A line graph showing change from baseline in IPSS Total Score over 12 weeks of treatment comparing tadalafil 5 mg and placebo. The x-axis represents duration of treatment in weeks, and the y-axis shows change from baseline. The tadalafil group shows a greater decrease in score than placebo, with data points marked at weeks 0, 2, 4, 8, and 12, including a statistically significant difference indicated at week 12.*

FDA Label Image

Tadalafil Tablets 20mg (Tadalafil Label 20mg)

The image shows a label for Tadalafil Tablets 20 mg, a film-coated oral tablet. It is labeled as generic for Cialis and manufactured by Accord Healthcare, Inc., Durham, NC. The label includes storage instructions, directions in English and Spanish for tablet intake, and spots for packaging details like lot number, expiration date, and insurance information. Preferred Pharmaceuticals Inc. logo is present at the top.*

FDA Label Image

Chemical Structure (Tadalafil Structure)

Chemical structure of Tadalafil, illustrating its molecular framework and connectivity of atoms in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.